Results 31 to 40 of about 379,801 (144)

Heterologous Vector—mRNA Based SARS-CoV-2 Vaccination Strategy Appears Superior to a Homologous Vector—Based Vaccination Scheme in German Healthcare Workers Regarding Humoral SARS-CoV-2 Response Indicating a High Boosting Effect by mRNA Vaccines

, 2023
Background: Longitudinal humoral SARS-CoV-2 (severe acute respiratory syndrome coronavirus type 2) immunity for up to 15 months due to vaccination, the efficacy of vaccination strategies (homologous, vector–vector versus heterologous, vector&ndash ...
Verena Haselmann, Michael Neumaier, Maximilian Kittel, Margot Thiaucourt, Catharina Gerhards, Michael Hetjens   +5 more
core   +1 more source

Immune response of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA COVID-19 vaccines in immunocompromised patients

Frontiers in Immunology, 2023
Due to rare but major adverse reactions to the AstraZeneca adenoviral ChAdOx1-S-nCoV-19 vaccine (ChAd), German health authorities recommended adults under 60 who received one dose of ChAd, to receive a second dose of the BioNTech mRNA BNT162b2 vaccine ...
Chang Chu, Anne Schönbrunn, Dorothea Fischer, Yvonne Liu, Yvonne Liu, Johann-Georg Hocher, Jutta Weinerth, Kristin Klemm, Kristin Klemm, Volker von Baehr, Bernhard K. Krämer, Bernhard K. Krämer, Bernhard K. Krämer, Bernhard K. Krämer, Saban Elitok, Saban Elitok, Berthold Hocher, Berthold Hocher, Berthold Hocher   +18 more
doaj   +1 more source

Immunogenicity and Durability of Antibody Responses to Homologous and Heterologous Vaccinations with BNT162b2 and ChAdOx1 Vaccines for COVID-19

, 2022
During the COVID-19 pandemic, vaccines were developed based on various platform technologies and were approved for emergency use. However, the comparative analysis of immunogenicity and durability of vaccine-induced antibody responses depending on ...
Eui Ho Kim, Park, Soonju, Sun Min Lee, Kim, Paul, Lee, Seo Jin, Soonju Park, Kim, Eui Ho, Nakyung Lee, David Shum, Lee, Nakyung, Shum, David, Seo Jin Lee, Paul Kim, Kim, Dong Ho, Dong Ho Kim, Dong-In Kim, Lee, Sun Min, Kim, Dong-In   +17 more
core   +1 more source

Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 infection

Emerging Microbes and Infections, 2022
Given emerging evidence of immune escape in the SARS-CoV-2 Omicron viral variant, and its dominance, effectiveness of heterologous and homologous boosting schedules commonly used in low-to-middle income countries needs to be re-evaluated.
Jing Lian Suah, Boon Hwa Tng, Peter Seah Keng Tok, Masliyana Husin, Thevesh Thevananthan, Kalaiarasu M. Peariasamy, Sheamini Sivasampu   +6 more
doaj   +1 more source

Adverse events data of following the homologous and heterologous booster vaccination.

, 2023
Adverse events data of following the homologous and heterologous booster vaccination.
Carmen Valenzuela Silva (17319206), Amitis Ramezani (6329339), Alireza Biglari (12152590), Sana Eybpoosh (2826068), Anahita Bavand (6329345), Mostafa Salehi-Vaziri (6273803), Mohammad Banifazl (17319212), Sarah Dahmardeh (17319209), Vicente Verez-Bencomo (17319200), Rahim Sorouri (17319194), Maria Eugenia Toledo-Romani (17319203), Ehsan Mostafavi (406077), Mona Sadat Larijani (17319197), Delaram Doroud (348344), Fatemeh Ashrafian (9619876)   +14 more
core   +1 more source

Heterologous Immunity Between SARS-CoV-2 and Pathogenic Bacteria

Frontiers in Immunology, 2022
Heterologous immunity, when the memory T cell response elicited by one pathogen recognizes another pathogen, has been offered as a contributing factor for the high variability in coronavirus disease 2019 (COVID-19) severity outcomes.
Peter J. Eggenhuizen, Boaz H. Ng, Janet Chang, Rachel M.Y. Cheong, Anusha Yellapragada, Wey Y. Wong, Yi Tian Ting, Julie A. Monk, Poh-Yi Gan, Poh-Yi Gan, Stephen R. Holdsworth, Stephen R. Holdsworth, Joshua D. Ooi   +12 more
doaj   +1 more source

Heterologous ChAdOx1 and Bnt162b2 vaccination induces strong neutralizing antibody responses against SARS-CoV-2 including delta variant with tolerable reactogenicity [PDF]

, 2022
OBJECTIVES: We assessed humoral responses and reactogenicity following the heterologous vaccination compared to the homologous vaccination groups. METHODS: We enrolled healthcare workers (HCWs) who were either vaccinated with ChAdOx1 followed by BNT162b2
Bae, Seongman, Kim, Shin-Woo, Kim, Byoungguk, Byoungguk Kim, Jeong, Hye Won, Jae-Hoon Ko, Kyoung Hwa Lee, Ah-Ra Kim, Lim, So Yun, Jang, Hee-Chang, Yoon Soo Park, Choi, Ju-Yeon, Sung Soon Kim, Kyong Ran Peck, Park, Woo-Jung, Ahn, Jin Young, Song, Young Goo, Kim, Sung Soon, Peck, Kyong Ran, Ko, Jae-Hoon, Woo-Jung Park, Kyoung-Ho Song, Kwon, Ki Tae, Sung-Han Kim, Chan Kim, Yong, Park, Yoon Soo, Jang, Sundong, Yong Chan Kim, Hye Won Jeong, Young Goo Song, Eun-Suk Kang, Choi, Won Suk, Sundong Jang, Shin-Woo Kim, Lee, Kyoung Hwa, Choi, Jun Yong, Ju-Yeon Choi, Hee-Chang Jang, Jin Young Ahn, So Yun Lim, Kang, Eun-Suk, Kim, Ah-Ra, Jun Yong Choi, Ki Tae Kwon, Won Suk Choi, Song, Kyoung-Ho, Kim, Sung-Han, Seongman Bae   +47 more
core   +2 more sources

BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and Malawi [PDF]

, 2011
BACKGROUND: BCG vaccination of infants is thought to provide good protection in all settings. This study investigated whether Malawian infants made weaker responses across a cytokine panel after BCG vaccination, compared with UK infants.METHODS: Diluted ...
Hazel M. Dockrell, Newport, Melanie J, Mvula, Hazzie, Weir, Rosemary E., Rose Blitz, Fine, P.E., Steven G. Smith, Nuala McGrath (230042), Crampin, Amelia C, Keith Branson (239422), Hazel M Dockrell (10414616), Sian Floyd, Fine, Paul E, Crampin, Amelia C., Weir, R.E., McGrath, N., Floyd, Sian, Rose Blitz (356877), Newport, M.J., Anne Ben-Smith (244056), Melanie Newport (4461202), Lalor, Maeve K., Hazzie Mvula, Lalor, M.K., Maeve K Lalor (16181825), Sian Floyd (239400), Weir, Rosemary E, Lalor, Maeve K, Gorak-Stolinska, P., Fine, Paul E., Nuala McGrath, Crampin, A.C., Ben-Smith, A., Steven G Smith (16181831), Maeve K. Lalor, Hazzie Mvula (271278), Smith, S.G., Mvula, H., Smith, Steven G., Smith, Steven G, Patricia Gorak-Stolinska (356875), Floyd, S., Blitz, R., McGrath, Nuala, Amelia C. Crampin, Gorak-Stolinska, Patricia, Rosemary E. Weir, Branson, K., Amelia C Crampin (10281422), Ben-Smith, Anne, Dockrell, Hazel M., Paul E. Fine, Paul E Fine (16181834), Blitz, Rose, Dockrell, H.M., Rosemary E Weir (16181828), Keith Branson, Anne Ben-Smith, Dockrell, Hazel M, Newport, Melanie J., Branson, Keith, Patricia Gorak-Stolinska, Melanie J. Newport   +62 more
core   +1 more source

Table_1_BNT162b2 COVID-19 vaccination in children alters cytokine responses to heterologous pathogens and Toll-like receptor agonists.docx

, 2023
BackgroundVaccines can have beneficial off-target (heterologous) effects that alter immune responses to, and protect against, unrelated infections. The heterologous effects of COVID-19 vaccines have not been investigated in children.AimTo investigate ...
Nicole L. Messina (10518191), Sonja Elia (16880196), David Burgner, Christine Axelrad, Kirsten P. Perrett, Thanh D. Dang (9413306), Andrés Noé, Susie Germano, Sonja Elia, Thanh D. Dang, Nigel Curtis, Christine Axelrad (13663399), Emma Burrell (16880193), Susie Germano (466440), David Burgner (268086), Nigel Curtis (150095), Emma Burrell, Nicole L. Messina, Andrés Noé (3620534), Kirsten P. Perrett (4874821)   +19 more
core   +1 more source

Exploring heterologous prime-boost vaccination approaches to enhance influenza control in pigs

Veterinary Research, 2020
Influenza A viruses evolve rapidly to escape host immunity. In swine, this viral evolution has resulted in the emergence of multiple H1 and H3 influenza A virus (IAV) lineages in the United States (US) pig populations.
Chong Li, Marie R. Culhane, Maxim Cheeran, Lucina Galina Pantoja, Micah L. Jansen, Deborah Amodie, Martha A. Mellencamp, Montserrat Torremorell   +7 more
doaj   +1 more source